My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 152

    1.

    Regression of choroidal metastases from breast carcinoma using aromatase inhibitors.

    Manquez ME, Shields CL, Karatza EC, Shields JA.

    Br J Ophthalmol. 2005 Jun;89(6):776-7. No abstract available. PMID: 15923523 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Adjuvant aromatase inhibitors for breast cancer.

    Howell A.

    Lancet. 2005 Aug 6-12;366(9484):431-3. No abstract available. PMID: 16084234 [PubMed - indexed for MEDLINE]Related articles

    3.

    Remission of macroglobulinemia during anastrozole treatment for breast cancer.

    Chettle C, Baker MA.

    N Engl J Med. 2005 Apr 21;352(16):1725-6. No abstract available. PMID: 15843681 [PubMed - indexed for MEDLINE]Related articles

    4.

    Current developments in hormonal therapy of breast cancer.

    Buzdar AU.

    Clin Breast Cancer. 2004 Sep;5 Suppl 1:S4-5. Review. No abstract available. PMID: 15347432 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A case of brain metastases from breast cancer that responded to anastrozole monotherapy.

    Ito K, Ito T, Okada T, Watanabe T, Gomi K, Kanai T, Mochizuki Y, Amano J.

    Breast J. 2009 Jul-Aug;15(4):435-7. Epub 2009 May 12. No abstract available. PMID: 19470131 [PubMed - indexed for MEDLINE]Related articles

    6.

    Management of choroidal metastases from breast carcinomas using aromatase inhibitors.

    Manquez ME, Brown MM, Shields CL, Shields JA.

    Curr Opin Ophthalmol. 2006 Jun;17(3):251-6.PMID: 16794437 [PubMed - indexed for MEDLINE]Related articles

    7.

    Aromatase inhibitors--a triumph of translational oncology.

    Swain SM.

    N Engl J Med. 2005 Dec 29;353(26):2807-9. No abstract available. Erratum in: N Engl J Med. 2006 Aug 3;355(5):533. PMID: 16382068 [PubMed - indexed for MEDLINE]Related articles

    8.

    Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.

    Buzdar AU.

    J Clin Oncol. 2007 May 20;25(15):2147-8; author reply 2148. No abstract available. PMID: 17513830 [PubMed - indexed for MEDLINE]Related articles

    9.

    ATAC trial update.

    de Castro G Jr.

    Lancet. 2005 Apr 2-8;365(9466):1225; author reply 1225-6. No abstract available. PMID: 15811448 [PubMed - indexed for MEDLINE]Related articles

    10.

    Alternative to tamoxifen effective for preventing breast cancer recurrence.

    [No authors listed]

    Mayo Clin Womens Healthsource. 2005 May;9(5):3. No abstract available. PMID: 15891689 [PubMed - indexed for MEDLINE]Related articles

    11.

    Long-term outcomes of aromatase inhibition for breast cancer.

    Toi M.

    Lancet Oncol. 2008 Jan;9(1):8-10. No abstract available. PMID: 18177815 [PubMed - indexed for MEDLINE]Related articles

    12.

    A step too far?

    [No authors listed]

    Lancet Oncol. 2005 Oct;6(10):731. No abstract available. Erratum in: Lancet Oncol. 2005 Nov;6(11):826. PMID: 16198972 [PubMed - indexed for MEDLINE]Related articles

    13.

    ERBB2 status and outcome of endocrine treatment.

    Miller WR.

    Lancet Oncol. 2008 Jan;9(1):4-5. No abstract available. PMID: 18177812 [PubMed - indexed for MEDLINE]Related articles

    14.

    Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.

    Zabolotny BP, Zalai CV, Meterissian SH.

    J Surg Oncol. 2005 Apr 1;90(1):26-30. Review.PMID: 15786432 [PubMed - indexed for MEDLINE]Related articles

    15.

    Extended adjuvant therapy for breast cancer--how much is enough?

    Prowell TM, Stearns V.

    J Natl Cancer Inst. 2007 Dec 19;99(24):1825-7. Epub 2007 Dec 11. No abstract available. PMID: 18073372 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Controversies in endocrine treatment: effective utilization of steroidal and nonsteroidal aromatase inhibitors: now and in the future. Forward.

    Aapro M.

    Anticancer Drugs. 2008 Mar;19 Suppl 2:S1. No abstract available. PMID: 18337639 [PubMed - indexed for MEDLINE]Related articles

    17.

    Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.

    Tuma RS.

    J Natl Cancer Inst. 2006 Jan 18;98(2):86-7. No abstract available. PMID: 16418506 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Anastrozole-induced hepatotoxicity.

    Zapata E, Zubiaurre L, Bujanda L, Piérola A.

    Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1233-4.PMID: 17033446 [PubMed - indexed for MEDLINE]Related articles

    19.

    NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer.

    Mamounas EP, Lembersky B, Jeong JH, Cronin W, Harkins B, Geyer C, Wickerham DL, Paik S, Costantino J, Wolmark N.

    Clin Breast Cancer. 2006 Dec;7(5):416-21. No abstract available. PMID: 17239269 [PubMed - indexed for MEDLINE]Related articles

    20.

    [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer]

    Longo F, Mansueto G.

    Tumori. 2004 Nov-Dec;90(6):1-12. Italian. No abstract available. PMID: 15762372 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity